On April 27th 2023 the steering committee of the SWITCH trial discussed the progress of the trial after randomisation of more than 200 patients. After a careful evaluation of the funding resources and the recruitment rate, the steering committee decided to stop the trial due to “lack of further funding” and “slow recruitment”. The randomisation of new patients was stopped by April 30th.
Even though we have not reached our target sample size, the recruitment of more than 200 patients in a academic trial on decompressive surgery in patients with severe intracerebral haemorrhage is a major success and we would like to thank you all for your incredible efforts to randomise so many patients over the last 9 years.